COVID‐19‐associated liver injury: Adding fuel to the flame
- 10 November 2023
- journal article
- review article
- Published by Wiley in Cell Biochemistry and Function
- Vol. 41 (8) , 1076-1092
Abstract
COVID‐19 is mainly characterized by respiratory disorders and progresses to multiple organ involvement in severe cases. With expansion of COVID‐19 and SARS‐CoV‐2 research, correlative liver injury has been revealed. It is speculated that COVID‐19 patients exhibited abnormal liver function, as previously observed in the SARS and MERS pandemics. Furthermore, patients with underlying diseases such as chronic liver disease are more susceptible to SARS‐CoV‐2 and indicate a poor prognosis accompanied by respiratory symptoms, systemic inflammation, or metabolic diseases. Therefore, COVID‐19 has the potential to impair liver function, while individuals with preexisting liver disease suffer from much worse infected conditions. COVID‐19 related liver injury may be owing to direct cytopathic effect, immune dysfunction, gut−liver axis interaction, and inappropriate medication use. However, discussions on these issues are infancy. Expanding research have revealed that angiotensin converting enzyme 2 (ACE2) expression mediated the combination of virus and target cells, iron metabolism participated in the virus life cycle and the fate of target cells, and amino acid metabolism regulated immune response in the host cells, which are all closely related to liver health. Further exploration holds great significance in elucidating the pathogenesis, facilitating drug development, and advancing clinical treatment of COVID‐19‐related liver injury. This article provides a review of the clinical and laboratory hepatic characteristics in COVID‐19 patients, describes the etiology and impact of liver injury, and discusses potential pathophysiological mechanisms.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20220467, BK20200840)
- National Natural Science Foundation of China (82000572, 82073914, 82173874, 82305046, 82304902)
This publication has 190 references indexed in Scilit:
- Amino acids and autophagy: cross-talk and co-operation to control cellular homeostasisAmino Acids, 2014
- Hepcidin and the iron enigma in HCV infectionVirulence, 2014
- Tissue-Specific Amino Acid Transporter Partners ACE2 and Collectrin Differentially Interact With Hartnup MutationsGastroenterology, 2009
- Upregulation of indoleamine 2,3‐dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus‐specific cytotoxic T lymphocytes in vivoLiver International, 2009
- Viral infection and iron metabolismNature Reviews Microbiology, 2008
- Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2Gut, 2005
- Pulmonary blood transit time and impaired arterial oxygenation in patients with chronic liver diseaseJournal of Gastroenterology, 2005
- Ido expression by dendritic cells: tolerance and tryptophan catabolismNature Reviews Immunology, 2004
- REGULATION OFENZYMES OF THEUREACYCLE ANDARGININEMETABOLISMAnnual Review of Nutrition, 2002
- Oxygen: Modulator of metabolic zonation and disease of the liverHepatology, 2000